| Year |
Citation |
Score |
| 2022 |
Chao A, Chen SJ, Chen HC, Tan KT, Hsiao W, Jung SM, Yang LY, Huang KG, Chou HH, Huang HJ, Chang TC, Chao AS, Lee YH, Wu RC, Lai CH. Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer. Biomedical Journal. PMID 36208860 DOI: 10.1016/j.bj.2022.09.004 |
0.335 |
|
| 2021 |
Weng CH, Wu RC, Chen SJ, Chen HC, Tan KT, Lee YS, Huang SS, Yang LY, Wang CJ, Chou HH, Chao AS, Chao A, Lai CH. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"? Journal of Molecular Medicine (Berlin, Germany). PMID 33768299 DOI: 10.1007/s00109-021-02064-4 |
0.442 |
|
| 2020 |
Wu RC, Chen SJ, Chen HC, Tan KT, Jung SM, Lin CY, Chao AS, Huang KG, Chou HH, Chang TC, Chao A, Lai CH. Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 32616873 DOI: 10.1038/s41379-020-0611-3 |
0.397 |
|
| 2019 |
Chen LY, Huang RL, Chan MWY, Yan PS, Huang TS, Wu RC, Suryo Rahmanto Y, Su PH, Weng YC, Chou JL, Chao TK, Wang YC, Shih IM, Lai HC. TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target. The Journal of Pathology. PMID 30883733 DOI: 10.1002/Path.5266 |
0.37 |
|
| 2018 |
Wu RC, Wang P, Lin SF, Zhang M, Song Q, Chu T, Wang BG, Kurman RJ, Vang R, Kinzler K, Tomasetti C, Jiao Y, Shih IM, Wang TL. Genomic landscape and evolutionary trajectories of ovarian cancer early precursor lesions. The Journal of Pathology. PMID 30560554 DOI: 10.1002/Path.5219 |
0.549 |
|
| 2018 |
Chao A, Lin CY, Wu RC, Lee YS, Lee LY, Tsai CL, Yang LY, Liu H, Chen SJ, Wang TH, Lai CH. The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2. Journal of Molecular Medicine (Berlin, Germany). PMID 30298385 DOI: 10.1007/s00109-018-1699-5 |
0.326 |
|
| 2017 |
Wu RC, Veras E, Lin J, Gerry E, Bahadirli-Talbott A, Baras A, Ayhan A, Shih IM, Wang TL. Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach. Cold Spring Harbor Molecular Case Studies. 3. PMID 29162652 DOI: 10.1101/mcs.a001693 |
0.569 |
|
| 2017 |
Anglesio MS, Papadopoulos N, Ayhan A, Nazeran TM, Noë M, Horlings HM, Lum A, Jones S, Senz J, Seckin T, Ho J, Wu RC, Lac V, Ogawa H, Tessier-Cloutier B, et al. Cancer-Associated Mutations in Endometriosis without Cancer. The New England Journal of Medicine. 376: 1835-1848. PMID 28489996 DOI: 10.1056/Nejmoa1614814 |
0.589 |
|
| 2016 |
Lai BR, Wu YT, Kuo YC, Hsu HC, Chen JS, Chen TC, Wu RC, Chiu CT, Yeh CN, Yeh TS. Targeted ultra-deep sequencing unveils a lack of driver-gene mutations linking non-hereditary gastrointestinal stromal tumors and highly prevalent second primary malignancies: random or nonrandom, that is the question. Oncotarget. PMID 27806309 DOI: 10.18632/oncotarget.12452 |
0.356 |
|
| 2016 |
Ayhan A, Kuhn E, Wu RC, Ogawa H, Bahadirli-Talbott A, Mao TL, Sugimura H, Shih IM, Wang TL. CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27767100 DOI: 10.1038/modpathol.2016.160 |
0.621 |
|
| 2016 |
Chao A, Wu RC, Jung SM, Lee YS, Chen SJ, Lu YL, Tsai CL, Lin CY, Tang YH, Chen MY, Huang HJ, Chou HH, Huang KG, Chang TC, Wang TH, et al. Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology. Gynecologic Oncology. PMID 27498588 DOI: 10.1016/j.ygyno.2016.07.114 |
0.36 |
|
| 2016 |
Suryo Rahmanto Y, Jung JG, Wu RC, Kobayashi Y, Heaphy CM, Meeker AK, Wang TL, Shih IM. Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells. The Journal of Biological Chemistry. PMID 26953344 DOI: 10.1074/Jbc.M115.707612 |
0.62 |
|
| 2015 |
Ayhan A, Mao TL, Suryo Rahmanto Y, Zeppernick F, Ogawa H, Wu RC, Wang TL, Shih IeM. Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors. The Journal of Pathology. Clinical Research. 1: 186-93. PMID 27499903 DOI: 10.1002/cjp2.22 |
0.579 |
|
| 2015 |
Wang Y, Shwartz LE, Anderson D, Lin MT, Haley L, Wu RC, Vang R, Shih IM, Kurman RJ. Molecular analysis of ovarian mucinous carcinoma reveals different cell of origins. Oncotarget. PMID 26355245 |
0.311 |
|
| 2015 |
Kashima H, Wu RC, Wang Y, Sinno AK, Miyamoto T, Shiozawa T, Wang TL, Fader AN, Shih IM. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression. Gynecologic Oncology. PMID 26343160 DOI: 10.1016/J.Ygyno.2015.08.025 |
0.568 |
|
| 2015 |
Kobayashi Y, Kashima H, Wu RC, Jung JG, Kuan JC, Gu J, Xuan J, Sokoll L, Visvanathan K, Shih IM, Wang TL. Mevalonate Pathway Antagonist Inhibits Proliferation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26109099 DOI: 10.1158/1078-0432.Ccr-14-3368 |
0.609 |
|
| 2015 |
Chui MH, Wang Y, Wu RC, Seidman J, Kurman RJ, Wang TL, Shih IeM. Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 437-45. PMID 25216223 DOI: 10.1038/Modpathol.2014.89 |
0.602 |
|
| 2014 |
Jung JG, Stoeck A, Guan B, Wu RC, Zhu H, Blackshaw S, Shih IeM, Wang TL. Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer. Plos Genetics. 10: e1004751. PMID 25356737 DOI: 10.1371/journal.pgen.1004751 |
0.581 |
|
| 2014 |
Guan B, Rahmanto YS, Wu RC, Wang Y, Wang Z, Wang TL, Shih IeM. Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis. Journal of the National Cancer Institute. 106. PMID 24899687 DOI: 10.1093/jnci/dju146 |
0.618 |
|
| 2014 |
Wu RC, Wang TL, Shih IeM. The emerging roles of ARID1A in tumor suppression. Cancer Biology & Therapy. 15: 655-64. PMID 24618703 DOI: 10.4161/cbt.28411 |
0.581 |
|
| 2014 |
Wu RC, Ayhan A, Maeda D, Kim KR, Clarke BA, Shaw P, Chui MH, Rosen B, Shih IeM, Wang TL. Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy. The Journal of Pathology. 232: 473-81. PMID 24338723 DOI: 10.1002/Path.4315 |
0.63 |
|
| 2014 |
Gao M, Wu RC, Herlinger AL, Yap K, Kim JW, Wang TL, Shih IeM. Identification of the NAC1-regulated genes in ovarian cancer. The American Journal of Pathology. 184: 133-40. PMID 24200849 DOI: 10.1016/J.Ajpath.2013.09.024 |
0.658 |
|
| 2014 |
Allo G, Bernardini MQ, Wu RC, Shih IM, Kalloger S, Pollett A, Gilks CB, Clarke BA. ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas Modern Pathology. 27: 255-261. PMID 23887303 DOI: 10.1038/modpathol.2013.144 |
0.375 |
|
| 2013 |
Yap KL, Sysa-Shah P, Bolon B, Wu RC, Gao M, Herlinger AL, Wang F, Faiola F, Huso D, Gabrielson K, Wang TL, Wang J, Shih IeM. Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axis. Plos One. 8: e69099. PMID 23922682 DOI: 10.1371/Journal.Pone.0069099 |
0.599 |
|
| 2013 |
Cope L, Wu RC, Shih IeM, Wang TL. High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome. Gynecologic Oncology. 128: 500-5. PMID 23200914 DOI: 10.1016/j.ygyno.2012.11.031 |
0.502 |
|
| 2012 |
Kuhn E, Wu RC, Guan B, Wu G, Zhang J, Wang Y, Song L, Yuan X, Wei L, Roden RB, Kuo KT, Nakayama K, Clarke B, Shaw P, Olvera N, et al. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. Journal of the National Cancer Institute. 104: 1503-13. PMID 22923510 DOI: 10.1093/Jnci/Djs345 |
0.554 |
|
| 2012 |
Thiaville MM, Stoeck A, Chen L, Wu RC, Magnani L, Oidtman J, Shih IeM, Lupien M, Wang TL. Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites. Plos One. 7: e36054. PMID 22567123 DOI: 10.1371/Journal.Pone.0036054 |
0.574 |
|
| Show low-probability matches. |